Hypertension in black South Africans

Area of Science:

• Cardiology
• Nephrology
• Public Health

Background:

• Hypertension is a significant health issue in Black populations globally, with prevalence rates ranging from 1-30% in adults.
• Documented differences exist in blood pressure (BP) levels between Black and White patients.
• These disparities are influenced by a complex interplay of genetic, endocrine, environmental, and socioeconomic factors.

Purpose of the Study:

• To review the genetic, endocrine, and environmental characteristics contributing to hypertension in Black populations.
• To examine racial differences in renal physiology and cardiac function related to blood pressure.
• To assess the efficacy of various antihypertensive drug classes in Black patients.

Main Methods:

• Literature review synthesizing existing research on hypertension in Black populations.
• Analysis of studies focusing on genetic predispositions, endocrine factors, and environmental influences.
• Evaluation of data on renal physiology, cardiac function, and drug responses.

Main Results:

• Racial disparities in renal physiology and socioeconomic status appear to be key drivers of BP differences.
• Black hypertensive patients often experience severe complications like cerebral hemorrhage and malignant hypertension, with less coronary artery disease.
• Standard treatments like beta-blockers and ACE inhibitors show reduced efficacy unless combined with thiazide diuretics.

Conclusions:

• Black hypertensive patients exhibit distinct clinical profiles and drug response patterns compared to other racial groups.
• Diuretics, vasodilators, and calcium channel blockers are more effective antihypertensive agents for Black patients.
• A tailored, profiled treatment approach is recommended for managing hypertension in Black individuals.